Efficacy of the Consumption of a Spinach Extract on Muscle Function in Subjects Over 50 Years of Age
NCT ID: NCT04612127
Last Updated: 2021-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2020-09-14
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects
NCT04506749
Effect of Ishige Okamurae Extract on Musculoskeletal Biomarkers in Adults With Relative Sarcopenia
NCT04617951
The Effect of Antioxidant Vitamin Supplementation on Muscle Performance and Redox Status After Eccentric Training
NCT01290458
Carnitine Supplementation and Skeletal Muscle Mass
NCT05009641
Effects of Decohexaenoic Acid Supplementation on Markers of Inflammatory Muscle Damage
NCT04125199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group - Spinach
Consumption for 90 days of spinach extract (1000mg)
Four capsules will be consumed per day, two with breakfast and two with lunch.
Dietary supplement consumption and physical exercise
The consumption time of the experimental product was 90 days and the control consumption time was 90 days.
During this time, training should be done three times a week.
control group Placebo (sucrose)
Four capsules will be consumed per day, two with breakfast and two with lunch.
Dietary supplement consumption and physical exercise
The consumption time of the experimental product was 90 days and the control consumption time was 90 days.
During this time, training should be done three times a week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary supplement consumption and physical exercise
The consumption time of the experimental product was 90 days and the control consumption time was 90 days.
During this time, training should be done three times a week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index less than 32.
* Subjects who do not develop physical exercise scheduled on a weekly basis.
* Subjects who have given written informed consent to participate in the study.
Exclusion Criteria
* Presence of absolute or relative contraindications dictated by the American College of Sports Medicine, for the performance of physical exercise.
* Presence of chronic diseases that prevent the performance of a physical exercise program (disabling arthropathies, moderate / severe chronic lung disease, ischemic heart disease under treatment, arrhythmias, etc.).
* Abuse in the ingestion of alcohol.
* Present hypersensitivity or intolerance to any of the components of the products under study.
* Inability to understand informed consent.
* Serious or terminal illnesses.
* Subjects with a body mass index above 32.
* Pregnant or lactating women.
* Inability to understand informed consent.
50 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Católica San Antonio de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francisco Javier López Román
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catholic University of Murcia
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCAMCFE-00016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.